SISTERS: Spasticity In Stroke Study - Randomized Study
Completed · Phase 4
Conditions studied: Severe Spasticity
In brief
To demonstrate that Intrathecal Baclofen (ITB) Therapy, compared to Best Medical Treatment (BMT), has superior efficacy in the treatment of severe spasticity in adult post-stroke patients with generalized spastic hypertonia who have not reached their therapy goal with other treatment interventions assessed by a decrease in the average Ashworth Scale (AS) score in the lower extremities.
Key facts
- Study ID
- NCT01032239
- Run by
- MedtronicNeuro
- People needed
- 61
- Starts
- 2009-11-01
- Expected to finish
- 2016-09-01
- Last updated by the study team
- 2018-02-15
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- To be eligible for inclusion into this study, patients must fulfill all of the following criteria prior to study enrollment:
- patient (or legal guardian) has been informed of the study procedures and has given written informed consent
- patient experienced last stroke > 6 months prior to enrollment
- patient presents spasticity in at least 2 extremities
- patient presents an Ashworth score ≥ 3 in a minimum of two of the affected muscle groups in the lower extremities
- patient is eligible to receive ITB Therapy following the Adult Spasticity Algorithm. A patient does not reach his/her therapy goal with other treatment interventions
- stable blood pressure: no change in hypertensive medication in last month (NOTE: ventriculoperitoneal shunts and valves can be present)
- if female, she must either be post-menopausal or surgically sterilized; or use a hormonal contraceptive, intrauterine device, diaphragm with spermicide, or condom with spermicide, for the duration of the study
- patient/family is willing to comply with study protocol including attending the study visits
You may not qualify if…
- To be eligible for inclusion in this study the patients must not meet any of the following criteria:
- patient/family is considered by the physician to be unable or unwilling to participate in long-term ITB Therapy management
- patient has known hypersensitivity to baclofen
- active systemic infection (NOTE: pressure sores are not a contraindication unless they are present near the implant sites)
- presence of a cardiac pacemaker, ICD, implantable neurostimulator or drug delivery device
- uncontrolled refractory epilepsy
- use of oral vitamin K antagonists, e.g. warfarin/coumadin; unless the patient can switch to another accepted anticoagulant (e.g. heparin, aggrenox, fragmin, plavix, ticlid) for the period of ITB test and implant
- patient is pregnant or breastfeeding
- patient received a Botulinum toxin injection less than 4 months ago
Where it is running
- University of California Irvine — Irvine, California, United States
- MedStar National Rehabilitation Network — Washington D.C., District of Columbia, United States
- Design Neuroscience Center — Doral, Florida, United States
- Rehabilitation Medical Group - Florida Hospital — Orlando, Florida, United States
- Tallahassee Neurological Clinic Department of Neurosurgery — Tallahassee, Florida, United States
- Saint Alphonsus Regional Med Center — Boise, Idaho, United States
- Research Medical Center — Kansas City, Missouri, United States
- Einstein Hospital/Moss Rehabilitation — Elkins Park, Pennsylvania, United States
- TIRR Memorial Herman Hospital — Houston, Texas, United States
- Sozialmedizinisches Zentrum Baumgartner Höhe Otto-Wagner-Spital — Vienna, Austria
- Landeskrankenhaus Hochzirl — Zirl, Austria
- Clin. Univ. UCL Saint Luc — Brussels, Belgium
- Universitair Ziekenhuis Gent — Ghent, Belgium
- Universitaire Ziekenhuizen Leuven, campus Pellenberg — Leuven, Belgium
- Kliniken Beelitz GmbH Neurologische Rehabilitationsklinik — Beelitz-Heilstätten, Germany
- Ambulantes Neurologisches Rehabilitationszentrum — Bonn, Germany
- Therapiezentrum Burgau — Burgau, Germany
- Rhein-Sieg-Klinik Dr. Becker Klinikgesellschaft — Nümbrecht, Germany
- Centro di Riabilitazione "Villa Beretta" — Costa Masnaga, Italy
- Fondazione Salvatore Maugeri Clinica del lavoro e della riabilitazione IRCSS — Pavia, Italy
- Afdeling Revalidatie Academisch Ziekenhuis Maastricht — Maastricht, Netherlands
- Univerzitetni rehabilitacijski inštitut Republike Slovenije Soča — Ljubljana, Slovenia
- Fundació Privada Institut de Neurorehabilitació Guttmann, Badalona — Barcelona, Spain
- Hospital Universitario La Paz — Madrid, Spain
- St George's Hospital — London, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.